Jiangsu Hengrui Medicine
600276.SS
$6.30
Share price
2.96%
Change (1 day)
-9.48%
Change (1 year)
Categories
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics
EPS for Jiangsu Hengrui Medicine (600276.SS)
EPS in 2023 (TTM): $0.09091
According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is $0.09091. In 2022 the company made an earnings per share (EPS) of $0.09065 a decrease over its 2021 EPS that were of $0.11.
EPS history for Jiangsu Hengrui Medicine from 2002 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $0.09091 | 0.29% |
| 2022 | $0.09065 | -17.1% |
| 2021 | $0.11 | -24.44% |
| 2020 | $0.14 | 20.3% |
| 2019 | $0.12 | 25.58% |
| 2018 | $0.09579 | 27.55% |
| 2017 | $0.07510 | 21.64% |
| 2016 | $0.06174 | 13.57% |
| 2015 | $0.05436 | 39.86% |
| 2014 | $0.03887 | 21.33% |
| 2013 | $0.03203 | 17.7% |
| 2012 | $0.02722 | 25.56% |
| 2011 | $0.02168 | 26.22% |
| 2010 | $0.01717 | 10.3% |
| 2009 | $0.01557 | 57.92% |
| 2008 | $0.009859 | 11.06% |
| 2007 | $0.008877 | 85.81% |
| 2006 | $0.004778 | 87.94% |
| 2005 | $0.002542 | 33.97% |
| 2004 | $0.001897 | 29.78% |
| 2003 | $0.001462 | 19.78% |
| 2002 | $0.001221 |